NextBioMedical Co Ltd (389650)

Currency in KRW
30,450
-600(-1.93%)
Closed·
Advertisement
Trading near 52-week Low
389650 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
30,05031,800
52 wk Range
30,050101,000
Key Statistics
Bid/Ask
30,450.00 / 30,500.00
Prev. Close
31,050
Open
30,850
Day's Range
30,050-31,800
52 wk Range
30,050-101,000
Volume
22.15K
Average Volume (3m)
42.31K
1-Year Change
-60.0917%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
389650 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
87,667
Upside
+187.90%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

NextBioMedical Co Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 87,667
(+187.90% Upside)

Earnings

Latest Release
10/08/2026
EPS / Forecast
-- / --
Revenue / Forecast
4.9B / 5.2B
EPS Revisions
Last 90 days

Compare 389650 to Peers and Sector

Metrics to compare
389650
Peers
Sector
Relationship
P/E Ratio
−7,081.0x7.5x−0.4x
PEG Ratio
69.840.020.00
Price/Book
5.3x1.0x2.6x
Price / LTM Sales
15.3x1.1x3.0x
Upside (Analyst Target)
189.9%87.0%49.0%
Fair Value Upside
Unlock26.9%6.5%Unlock

Next Biomedical Co.,Ltd. engages in the research and development, production, and development of therapeutics, drug delivery system and drug-medical device products in South Korea. It offers hemostatic material for endoscope; and microspheres for vascular embolization. The company was founded in 2014 and is based in Incheon, South Korea.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
171.50K2.07%5.33B
Other Institutional Investors
30.00K0.36%931.50M
Public Companies & Retail Investors
8.08M97.57%250.75B
Total
8.28M100.00%257.01B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Norges Bank Investment Management1.64%135,9464,221,123
Government Pension Fund Global1.64%135,9464,221,123

FAQ

What Is the NextBioMedical (KOSDAQ: 389650) Share Price Today?

The NextBioMedical stock price today is 30,450 KRW.

What Stock Exchange Does NextBioMedical (389650) Trade On?

NextBioMedical is listed and trades on the KOSDAQ.

What Is the Ticker (Stock Symbol) for NextBioMedical?

The stock symbol (also called a 'ticker') for NextBioMedical is "389650."

What Is the Current NextBioMedical Market Capitalisation?

As of today, NextBioMedical (KOSDAQ: 389650) market cap is 257.01B KRW.

What Is NextBioMedical's (389650) Earnings Per Share (TTM)?

The NextBioMedical EPS is currently -4 (Trailing Twelve Months).

When Is the Next NextBioMedical Earnings Date?

NextBioMedical's next earnings report will be released on 13/11/2026.

Is 389650 a Buy or Sell From a Technical Analyst Perspective?

Based on today's NextBioMedical moving averages and other technical indicators, the daily buy/sell signal for 389650 stock is Strong Sell.

How Many Times Has NextBioMedical Stock Split?

NextBioMedical has split 0 times. (See the 389650 stock split history page for full effective split date and price information.)

What is the current trading status of NextBioMedical (KOSDAQ: 389650)?

As of 08/09/2026, NextBioMedical (389650) is trading at a share price of 30,450 KRW, with a previous close of 31,050 KRW. The stock has fluctuated within a day range of 30,050 KRW to 31,800 KRW, while its 52-week range spans from 30,050 KRW to 101,000 KRW.

What Is NextBioMedical (389650) Price Target According to Analysts?

The average 12-month price target for NextBioMedical is 87,667 KRW, with a high estimate of 90000 KRW and a low estimate of 83000 KRW. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +187.90% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.